About: BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2005

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) im Jahr 2005 veröffentlichter wissenschaftlicher Artikel (de) article scientifique (publié 2005) (fr) 2005 թվականին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована в січні 2005 (uk) artículu científicu espublizáu en xineru de 2005 (ast) artikull shkencor i botuar më 01 janar 2005 (sq) scientific article published on 01 January 2005 (en)
publication date	wds:Q80297430-8E286274-9D98-4838-A6F8-B46531585616
publication date	2005-01-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q80297430-02A207A1-061B-4969-8736-23F78AB6228A wds:Q80297430-0657645F-F4C1-49DC-927D-23A077DD8D8C wds:Q80297430-0E015158-7F38-4C3F-8D10-311B2443584D wds:Q80297430-147048BE-FD5E-4D35-8AF9-DE3E2AD9E21E wds:Q80297430-450D520F-F5B4-4888-97BC-A11394273980 wds:Q80297430-453D8901-BBD8-435B-A25D-BB07C877FB45 wds:Q80297430-82E1CFDB-BB57-44CD-B1CB-52C161F0EF2A wds:Q80297430-8F7EFF50-F2B1-47EE-8C3E-048309AF4481 wds:Q80297430-9022539F-68B0-40E1-A11D-D454D5A7FF9C wds:Q80297430-97A4DCBB-E1AC-42F4-844B-6FE45FEDC443 wds:Q80297430-A4454FB8-8F41-4F40-8FD6-3C44A56055FE wds:Q80297430-A6869EE1-D0F4-4860-8327-F049BC461553 wds:Q80297430-B51DD8BB-CADF-4403-A152-E496B1C9E0F4 wds:Q80297430-DA6939BE-F0B6-46F5-A02C-26E5819EA98C wds:Q80297430-DFE0BA5F-AF18-4FFA-83DD-B08842555850 wds:Q80297430-F4793D3C-766A-4EED-891D-3524BB6F024E wds:Q80297430-F667E804-225D-4BFD-A373-9440AA58B924
cites work	A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue. Nomograms as predictive models "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease Prostate-specific antigen and prostate gland volume: Correlation and clinical application Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers Partin tables: past and present
author name string	wds:Q80297430-3CBE9094-E1C5-4927-BB83-EBAFB3605084 wds:Q80297430-5C454C41-A203-4FE2-AE6C-1C054FE5E9E3
author name string	Kevin M Slawin Eduardo Canto
rdfs:label	BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (en) BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (nl) BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (sq)
skos:prefLabel	BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (en) BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (nl) BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (sq)
name	BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (en) BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (nl) BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (sq)
author	wds:Q80297430-FB5DDEAA-F39F-4AF1-8BD7-E37FBEC409A9
author	Shahrokh Shariat
title	wds:Q80297430-B99FC88E-E5F2-4455-978E-C30C14F06426
title	BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia (en)
page(s)	wds:Q80297430-2E3C389A-3E0E-4781-996F-720CF1AD88EB
page(s)	S52-6
instance of	wds:Q80297430-1E67A2CD-D2A1-4A3F-B8ED-EBC019101DD5 wds:Q80297430-d0db3a68-e6d5-4757-8e15-b5bf9e96d870
instance of	review article scholarly article
main subject	wds:Q80297430-5E4D7528-9B6E-4D53-8BC1-7E47A93DFAF8
main subject	prostatic hypertrophy
PubMed ID	wds:Q80297430-05F4DF0A-8552-4055-A0EF-F176E116843B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16985891
PubMed ID	16985891
published in	wds:Q80297430-3C395D94-BA69-4A47-996D-435E0C3CCC13
published in	Reviews in urology
volume	wds:Q80297430-532978B3-C465-4095-AACB-63EF52A6B5A1
volume	7 Suppl 8
PMCID	wds:Q80297430-EE56CDCE-72EB-4FB3-BC7D-1898A9914EA5
PMCID	1477630
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80297430
is cites work of	Screening for prostate cancer: an update. Does prostate growth confound prostate specific antigen velocity? Data from the Baltimore longitudinal study of aging A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies Office evaluation of male patients with lower urinary tract symptoms.
is cites work of	wds:Q31171895-DA541D1D-D9A3-47D3-B7F7-A2E7C31D2121 wds:Q33320106-A297D094-295D-44E6-8AD9-7F4B626920A4 wds:Q37507776-7CEC53BF-8229-4BC1-BA33-9203F004CE03 wds:Q51317315-EBA0B8D7-5B54-44C1-9497-47E0C98F15D5 wds:Q37338478-7ED56BA9-20DB-4BC1-AEDA-E18C89D22DCE

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software